Literature DB >> 16439400

Venous thromboembolism.

Andrew D Blann1, Gregory Y H Lip.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16439400      PMCID: PMC1352055          DOI: 10.1136/bmj.332.7535.215

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  27 in total

1.  Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults.

Authors:  Richard H White; Helen K Chew; Hong Zhou; Arti Parikh-Patel; David Harris; Danielle Harvey; Theodore Wun
Journal:  Arch Intern Med       Date:  2005 Aug 8-22

2.  Duration of anticoagulation following venous thromboembolism: a meta-analysis.

Authors:  David Ost; Josh Tepper; Hanako Mihara; Owen Lander; Raphael Heinzer; Alan Fein
Journal:  JAMA       Date:  2005-08-10       Impact factor: 56.272

Review 3.  Elevated clotting factor levels and venous thrombosis.

Authors:  Rogier M Bertina
Journal:  Pathophysiol Haemost Thromb       Date:  2003 Sep-2004 Dec

Review 4.  New anticoagulants.

Authors:  J I Weitz; S M Bates
Journal:  J Thromb Haemost       Date:  2005-08       Impact factor: 5.824

Review 5.  The epidemiology of venous thromboembolism.

Authors:  Richard H White
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

Review 6.  Risk factors for venous thromboembolism.

Authors:  Frederick A Anderson; Frederick A Spencer
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

Review 7.  Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system.

Authors:  Mark A Crowther; John G Kelton
Journal:  Ann Intern Med       Date:  2003-01-21       Impact factor: 25.391

8.  Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.

Authors:  H R Büller; B L Davidson; H Decousus; A Gallus; M Gent; F Piovella; M H Prins; G Raskob; A E M van den Berg-Segers; R Cariou; O Leeuwenkamp; A W A Lensing
Journal:  N Engl J Med       Date:  2003-10-30       Impact factor: 91.245

9.  Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.

Authors:  Alexander G G Turpie; Kenneth A Bauer; Bengt I Eriksson; Michael R Lassen
Journal:  Arch Intern Med       Date:  2002-09-09

10.  The cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against thromboembolism following major orthopedic surgery.

Authors:  A Gordois; J Posnett; L Borris; P Bossuyt; B Jönsson; E Levy; G de Pouvourville
Journal:  J Thromb Haemost       Date:  2003-10       Impact factor: 5.824

View more
  24 in total

Review 1.  Clinical opinion: the biologic and pharmacologic principles for age-adjusted long-term estrogen therapy.

Authors:  Morris Notelovitz
Journal:  MedGenMed       Date:  2006-03-28

2.  Venous thromboembolism: potentially dangerous diagnostic pitfalls arise from diagnostic tests.

Authors:  Oscar M Jolobe
Journal:  BMJ       Date:  2006-02-11

3.  Venous thromboembolism: stockings are important.

Authors:  Daniel A Shaerf
Journal:  BMJ       Date:  2006-02-11

4.  Venous thromboembolism: heparins are of porcine origin.

Authors:  Colin White
Journal:  BMJ       Date:  2006-02-11

Review 5.  Real-world effectiveness and safety of pharmacological thromboprophylaxis in patients undergoing primary total hip and knee arthroplasty: A narrative review.

Authors:  Astrid Blicher Schelde; Astrid Eliasen; Jonas Bjerring Olesen; Thomas Bo Jensen; Espen Jimenez-Solem
Journal:  J Orthop       Date:  2019-11-12

6.  Is thromboprophylaxis effective in reducing the pulmonary thromboembolism?

Authors:  Fereshteh Rajabi; Masoumeh Sadeghi; Fereshteh Karbasian; Ali Torkan
Journal:  ARYA Atheroscler       Date:  2012

7.  Venous Thromboembolism Prophylaxis in Neurocritical Care Patients: Are Current Practices, Best Practices?

Authors:  K M Sauro; A Soo; A Kramer; P Couillard; J Kromm; D Zygun; D J Niven; S M Bagshaw; H T Stelfox
Journal:  Neurocrit Care       Date:  2019-04       Impact factor: 3.210

8.  Familial pulmonary thromboembolism with a prothrombin mutation and antithrombin resistance.

Authors:  Ritsu Yoshida; Shingo Seki; Jun Hasegawa; Tatsuya Koyama; Koji Yamazaki; Akira Takagi; Tetsuhito Kojima; Michihiro Yoshimura
Journal:  J Cardiol Cases       Date:  2018-03-27

Review 9.  The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants.

Authors:  Andrew D Blann; Chee W Khoo
Journal:  Vasc Health Risk Manag       Date:  2009-08-20

10.  Prevention and treatment of venous thromboembolism in the elderly patient.

Authors:  Enrico Tincani; Mark A Crowther; Fabrizio Turrini; Domenico Prisco
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.